LawrenceDavidGinsbergMD

Clinical Trials

• Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01

  Completed

  Phase 2

• Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01

  Completed

• Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders Start of enrollment: 2009 Feb 01

  Completed

  Phase 2

• Biomarker and DNA Collection in Subjects Participating in Protocol 22003 Start of enrollment: 2009 May 01

  Completed

• Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis Start of enrollment: 2009 Aug 01

  Completed

• PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01

  Completed

  Phase 3

• Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder Start of enrollment: 2014 May 01

  Terminated

  Phase 2

• Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01

  Completed

  Phase 3

• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18

  Completed

  Phase 3

• DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder Start of enrollment: 2016 Oct 24

  Terminated

  Phase 4

• Join now to see all